Background: Endometrial and cervical cancers are common worldwide for gynecological cancers. MRI has been shown to be the most accurate non-invasive technique for endometrial and cervical cancer staging, which is necessary to make the right medical treatment decision, since accurate staging is crucial for the appropriate treatment. Functional MRI (dynamic contrast, diffusion-weighted imaging) in perfect combination with conventional MRI are used to make correct diagnosis and accurate staging. Objective: The aim of the study is to assess the role of magnetic resonance imaging (MRI) in staging of endometrial and cervical cancer. Methods: This study was carried out at Radio diagnosis Department, Zagazig University Hospitals, the present study was carried on 37 patients of endometrial and cervical cancer. Conventional MRI, contrast enhanced MRI and diffusion weighted imaging were done. Results: The combination of conventional and functional MR images is particularly beneficial for the evaluation of endometrial and cervical carcinoma stages. This study included 37 female patients with postmenopausal bleeding, vaginal abnormal bleeding, vaginal abnormal discharge and pelvic pain due to several pathologies, 24 cases of endometrial carcinoma and 13 cases of cervical cancer. All patients underwent conventional MRI, MRI with contrast and diffusion weighted imaging. Biopsies were made for all cases for tissue characterization and histological types identification. Conclusion: Our results show that magnetic resonance imaging is the best technique for initial endometrial and cervical tumor staging. In order to obtain high diagnostic accuracy, adequate patient preparation, protocol optimization and MRI reporting expertise are essential.
INTRODUCTION
he most common female reproductive tract cancer is endometrial carcinoma. The average diagnostic age is 61 years. The rising incidence discovered in recent times is expected to be due both to higher life expectancy and increasing obesity rates. Cervical carcinoma is the third most common malignant in gynecology. The average start-up age is 48 years. The widespread use of Papanicolaou screening and successful in situ carcinoma treatment has resulted in a large decrease in cervical cancer in developed countries (1) . Ninety percent of endometrial cancer patients suffer from abnormal vaginal bleeding, most commonly postmenopausal, and bleeding tends to happen early in the course of cancer (2) . The main risk factor for cancer cervix is human papilloma virus (HPV), especially subtypes 16 (mainly SCC-related) and 18 (mainly adenocarcinoma-related). Low socioeconomic background, early sex life, multiple partners, immune suppression and smoking are other predisposing factors (3) .
The
International Federation of Gynecology and Obstetrics (FIGO) staging system is the most broadly trained endometrial and cervical cancer staging system. In June 2009, a new update of the FIGO staging system was done, due to modification in our information about the tumor biology. The endometrial and cervical cancer staging system of FIGO explains its different clinical management techniques. Endometrial carcinoma management is mainly surgical, while cervical carcinoma totally depends on the FIGO stage. MR imaging has an essential role in assessing and managing the degree of the disease (4) . Adequate pre-operative evaluation of the invasiveness of endometrial carcinoma is essential for surgical planning. Magnetic resonance imaging (MRI) is actually the best method for preoperatively assessing the local invasiveness of uterine cancers (5) . MRI is used mainly to assess tumor morphology and local extent; it adequately assesses tumor characteristics with significant prognostic value such as size, endocervical extension, parametrial invasion and pelvic side wall or nearby organs (bladder, rectum) invasion (6) . The gynecological protocol for pelvic MR imaging contains axial, sagittal and coronal T2-weighted images. Abdomen and pelvis axial spin-echo T1-or T2-weighted images to describe lymphadenopathy, hydronephrosis and abnormalities of the bone marrow . Many studies have noted the additional benefit of dynamic contrast enhancement in the assessment of myometrial invasion in endometrial carcinoma patients (8) . Dynamic contrast enhanced T1-weighted gradient echo imaging can improve the description and demarcation of small cervical lesions of 3 mm or more with a sensitivity of 98% and provide helpful information for surgical planning (9) . Diffusion-weighted imaging (DWI) plays an extremely approved role in routine cervical and endometrial carcinoma staging as it rises the conspicuity of tumors and helps in image characterization (8) . Compared to nearby tissues, the tumor usually shows restricted diffusion, this is seen as a high signal intensity area on diffusionweighted images and a hypo intensity area on apparent diffusion coefficient (ADC) maps. In general, DWI can adequately illustrate the depth of myometrial invasion of endometrial cancer patients (8) .
PATIENTS & METHODS Patients
From May 2018 to December 2018, 37 female patients with endometrial and cervical carcinoma [24 endometrial carcinoma and 13 cancer cervix with ages range from 31 years-to 80 years with mean age group ± SD (57 ± 11.6)] were referred from Obstetrics and Gynecology department to Radio-diagnosis department; Zagazig University Hospitals, after obtaining institutional board review from our hospital. Written informed consent was obtained from all participants and the study was approved by the research ethical committee of Faculty of Medicine, Zagazig University. The work has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for studies involving humans. All patients were subjected to the following: All the patients were subjected to intravenous Gadolinium Diethylene Triamine Penta Acetic acid (GD-DPTA) with dose 0.1-0.2 mmol /kg BW. Post contrast axial oblique and sagittal T1 spin echo with fat suppression was performed utilizing the following parameters TR 600 ms, TE 14 ms, matrix 205×512, slicethickness: 3-4mm with an interslice gap of 1-2 mm, FOV 240mm and a flip angle of 90).
Most commonly, dynamic contrastenhanced T1-weighted fat-suppressed images are acquired at time of 30, 60, and 120 seconds after administration of contrast material, Next, delayed phase at time of 3-4 minutes after administration of contrast material in axial oblique T1-weighted fat-suppressed along the axis of the uterus.
In endometrial cancer, the dynamic contrast improves the accuracy as it improved tumor-tomyometrial contrast that is generally seen on delayed (2-4 minutes after administration of contrast material) images, with most endometrial tumors appearing hypointense against the enhancing myometrium. An additional benefit of contrast-enhanced imaging is that small tumors that may be difficult to define at T2-weighted imaging may appear hyper vascular in the early arterial phase.
In cervical cancer, the dynamic contrast improves the accuracy as it depicts small cervical tumors. It also depicts bladder wall involvement in those with advanced disease.
The Dynamic curve in malignant tissue demonstrate rapid, intense enhancement followed by a relatively rapid washout compared to normal tissue. e. Diffusion weighted magnetic resonance imaging: Carried out on the same MR imager using a Single-Shot Spin-Echo type echo planar sequence under free breathing with the following parameters (Time of repetition "TR" 2900 ms, Echo time "TE" 70 ms, matrix 512×512, slice-thickness 4mm with an interslice gap of 1-2 mm and FOV 240 mm) were acquired on the axial plane.
The diffusion-sensitizing gradients were done with a b factor of 0-500 and 1000 s/mm 2 for each patient. ADC maps were automatically reconstructed for all diffusion weighted images and used for the measurement of ADC value.
Image interpretation:
Cases were revised and analyzed to assess: -Signal intensity and homogeneity (homogenous or heterogeneous) on T1 and T2 weighted images compared with that of adjacent myometrium. -Tumor morphology (tumor size, characteristics, also assessment of enhancement pattern on post contrast image).
-Detection of the junctional zone on T2-weighted images as a band of low signal intensity just beside the endometrium, myometrial invasion was detected when it is disrupted by lesions. -Parametrial invasion (disruption of lowintensity cervical stromal rim).
-Pelvic sidewall invasion (extension of tumor within 2 mm of pelvic sidewall, hydroureter and hydronephrosis).
-Bladder/bowel mucosal involvement (tumor infiltrating bladder/bowel mucosa).
-DW-MR images were observed in combination with conventional MRI for anatomical correlation of the lesion. -ADC examination the largest possible region of interest (ROI) was put on the lesion on a single image slice. Care was taken to avoid contamination of this ROI by adjacent normal tissue or by areas of fluid/necrosis by referring to conventional T2-weighted image. The mean ADC value is measured to every lesion.
STATISTICAL ANALYSIS The findings of imaging studies were evaluated and correlated to clinical and histopathological results. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy intervals were calculated. RESULTS This study included 37 female patients, they were "24" cases of endometrial carcinoma and "13" cases of cancer cervix. Regarding age distribution in endometrial carcinoma patients, their ages ranged from (40 to 80 years) with the mean age was 61 years; the most common age group was 60-70 years old. Regarding age distribution in cancer cervix patients, their ages ranged from (30 to 70 years) with the mean age was 50 years; the most common age group was 50-60 years old. Regarding the pathological types, the most common pathological type of endometrial carcinoma in our study was endometrial adenocarcinoma seen in 11 patients which represents (45.7%) of the total, the most common pathological type of cancer cervix in our study was cervical squamous cell carcinoma seen in 8 patients which represents (61.5%) of the total, as demonstrated in table (1). Many clinical symptoms were shown in our study, the commonest presentation was postmenopausal bleeding which represents 62.5% in patients with endometrial carcinoma and 46.2% in patients with carcinoma of the cervix. Other symptoms were offensive watery discharge and abnormal vaginal bleeding which represents 12.5% and 25% respectively in patients with endometrial carcinoma and 30.8% and 23% respectively in patients with carcinoma of the cervix as shown in 
DISCUSSION
Endometrial cancer patients are mainly treated with hysterectomy; therefore, staging is performed during surgery and histological analysis. Magnetic resonance imaging (MR) can adequately describe the extent of endometrial cancer during diagnosis and help stratify the risk, which dictates the therapeutic course, in combination with the tumor grade and histologic subtype (10) . During clinical examination, cervical carcinoma is staged because many tumors cannot be operated during patient presentation. Principles of preoperative MR imaging are not formally involved in the revised FIGO staging system, as cervical carcinoma is more common in developing countries, with minimal imaging resources. However, MR imaging is highly sensitive and specific for illustrating essential prognostic factors and is also recommended as a clinical examination assistant when available .
The combination of conventional and functional MR images is particularly helpful in evaluating essential prognostic factors such as tumor size, parametrial and pelvic side wall invasion, nearby organ invasion and lymph node metastases (11) . This study included 37 female patients; they were 24 cases of endometrial carcinoma (b) and 13 cases of cancer cervix. All the patients underwent Conventional MRI, MRI with contrast and diffusion weighted imaging. Biopsies were performed for all cases for tissue characterization and to identify the histological types.
In our study we found that the most common age group in endometrial carcinoma is an average of (40-80) years and that the mean age of the studied group was 60.75 ± 9.78. Similar figure was observed in the study conducted by Habib et al (12) that the age of the patients ranged from (40-78) years and the mean age was 53.4 ± 7.29.
We also found that the most common age group affected by cancer cervix was between (30-70) years old and that the mean age of the studied group was 50 ±10.56. Similar figure was observed in the Mansour et al (13) study, which reported that the age of the patients ranged from (30-80) years old and the mean age was 49.
The commonest symptom presented by Habib et al (12) in endometrial carcinoma was post-menopausal bleeding with a total percentage (75%) similar figure is noted in our study as the most common presenting symptom was postmenopausal bleeding with a total percentage 62.5% of the cases.
The commonest symptom presented by Dhoot et al (14) in cancer cervix was irregular uterine bleeding with a total percentage (86.6%) while the commonest symptom presented in the current study was postmenopausal bleeding with a total percentage 46.2%.
In our study, endometrial adenocarcinoma represents (45.7%) of cases, indicates the commonest histological type of endometrial malignancy. This incidence was almost compatible with studies conducted by Kierans et al (15) and Habib et al (13) , which showed that the most common pathological type of endometrial malignancy examined was endometrial adenocarcinoma, which accounted for 94% and 90% respectively of the total cases studied.
In our study, squamous cell carcinoma represents (61.5%) of cases indicates the commonest histological type of cancer cervix. This incidence was nearly compatible by the studies done by Mansour et al (13) and Article et al (16) , which reported that the most common pathological type of the examined cancer cervix was the squamous cell carcinoma representing 72% and 90.7% of the total studies cases respectively.
Endometrial In our study, the overall accuracy of the MRI in endometrial and cervical malignancy staging is 91.6% and 92.3% respectively. Keeping with the study by Rauch et al (1) shows 89% sensitivity with 99% specificity. CONCLUSION In our series, we evaluated the role of the conventional and functional MRI in endometrial and cervical cancer diagnosis and staging.
MRI in our opinion is the optimal imaging modality in terms of accuracy for assessment of tumors, and plays an essential role in staging for proper therapeutic planning. To achieve high diagnostic accuracy, we need a good patient preparation, protocol optimization and MRI reporting skill.
Our results indicate that MRI is the proper noninvasive modality for endometrial and cervical tumors detection and staging, and least time-consuming technique, that play an essential role in treatment decision.
